Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

 
<< vorige   
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             2104 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
2001 United States Policy Implications of Generic Substitution of Branded Human Immunodeficiency Virus Medications Hogue, S.
 2013
 16 7 p. A364-A365
nvt p.
 artikel
2002 Unmet Health Needs of Immigrants Living in Greece During the Economic Crisis: The Long-Term Impact for the Health Care System Kaitelidou, D.
 2013
 16 7 p. A462-
1 p.
 artikel
2003 Unmet Needs and Biologic Use Among Patients with Rheumatoid Arthritis in Brazil de Renteria, J.
 2013
 16 7 p. A719-
1 p.
 artikel
2004 Un Seguro Nacional De Enfermedades Catastróficas: Fundamentos Para Su Implementación Tobar, F.
 2013
 16 7 p. A673-
1 p.
 artikel
2005 Update of the Patient-Reported Outcome and Quality of Life Instruments Database (PROQOLID): Inclusion of E-PRO Information Caron, M.
 2013
 16 7 p. A584-
1 p.
 artikel
2006 Update on Pharmacoeconomics in Nutrition: Parenteral Glutamine Supplement in Intensive Care Unit Patients Povero, M.
 2013
 16 7 p. A371-
1 p.
 artikel
2007 Uptake of Denosumab in the Treatment of Osteoporosis in the Czech Republic Fuksa, L.
 2013
 16 7 p. A557-
1 p.
 artikel
2008 Urban Health Networks and Perinatal Health Risk in Argentina Maceira, D.
 2013
 16 7 p. A673-
1 p.
 artikel
2009 Usefulness of a Commercial Hospital Claims Database to Identify Current Anti-Vascular Endothelial Growth Factor Treatment Patterns in Patients with Exudative Age-Related Macular Degeneration in Japan Narimatsu, A.
 2013
 16 7 p. A584-
1 p.
 artikel
2010 Usefulness of the Hypoglycemia Perspectives Questionnaire (HPQ) in Management of Patients with Type 2 Diabetes Ionova, T.I.
 2013
 16 7 p. A447-
1 p.
 artikel
2011 Use of Antenatal Corticosteroids Lowers Hospitalization Costs Related to Prematurity Meneguel, J.
 2013
 16 7 p. A332-
1 p.
 artikel
2012 Use of Antibiotics and Prescription Medication in Influenza Disease in the United Kingdom Meier, G.
 2013
 16 7 p. A347-
1 p.
 artikel
2013 Use of Beta Blocking Agents in Serbia in the Period from 2007 to 2011 Year Milijasevic, B.
 2013
 16 7 p. A517-
1 p.
 artikel
2014 Use of Calcium Channel Blockers in Serbia in the Period from 2007 to 2011 Year Milijasevic, D.
 2013
 16 7 p. A516-
1 p.
 artikel
2015 Use of Clinical Practice Guidelines by Physicians in Japan Shimbo, T.
 2013
 16 7 p. A485-
1 p.
 artikel
2016 Use of Diuretics in Serbia in the Period from 2007 to 2011 Year Tomic, Z.
 2013
 16 7 p. A517-
1 p.
 artikel
2017 Use of Multivariate Bayesian Evidence Synthesis to Reduce Uncertainty Around Clinical Effectiveness and Quality of Life Estimates Bujkiewicz, S.
 2013
 16 7 p. A608-A609
nvt p.
 artikel
2018 Use of Real-World Evidence (RWE) to Validate a Trial-based Health Economic Model Munakata, J.
 2013
 16 7 p. A325-
1 p.
 artikel
2019 Use of Surrogate Outcomes in Health Technology Assessments (HTAs) Jaksa, A.
 2013
 16 7 p. A613-
1 p.
 artikel
2020 Use of the Clinical Practice Research Datalink (CPRD) to Assess ‘Real-World’ Management of Tuberous Sclerosis Complex (TSC) in the United Kingdom Demuth, D.
 2013
 16 7 p. A581-A582
nvt p.
 artikel
2021 Use of the French Claims and Hospitalisations Database to Estimate the Prevalence and Incidence of Parkinson’s Disease in France Blin, P.
 2013
 16 7 p. A620-
1 p.
 artikel
2022 User and Treatment Characteristics of Oral Contraceptives in the European Union Bezemer, I.D.
 2013
 16 7 p. A340-
1 p.
 artikel
2023 User Preferences for Stroke Services in Wales Fargher, E.A.
 2013
 16 7 p. A534-
1 p.
 artikel
2024 Using a Cause-Of-Death-Based Mortality Model to Identify the Individuals Who Would Benefit Most from Primary Prevention with Statins Martin, C.
 2013
 16 7 p. A517-
1 p.
 artikel
2025 Using an Excel Calculator to Estimate Ankylosing Spondylitis Costs in Turkey Baser, O.
 2013
 16 7 p. A577-
1 p.
 artikel
2026 Using a “Standards of Care Economic Model” to Quantify Barriers and Potential Solutions to Providing Optimal Guideline-Driven Care to Patients with Diabetes Mellitus in the United States Hughes, K.E.
 2013
 16 7 p. A453-
1 p.
 artikel
2027 Using Feedback from Patients in Determining Suitability of the Perceived Deficits Questionnaire (PDQ) and the Resource Utilization in Dementia-Lite (RUD-Lite) for Use in Clinical Trials in Prodromal Alzheimer’s Disease Lenderking, W.R.
 2013
 16 7 p. A604-
1 p.
 artikel
2028 Using Lower Cost, Lower Efficacy Interventions Can Improve Population Health Outcomes Under Budget Constraints Arbel, R.
 2013
 16 7 p. A617-
1 p.
 artikel
2029 Using Mobile Technology (mHealth) to Develop the Value Story for New Drugs, Devices and Therapies: Optimising User Engagement and Addressing Payer Concerns Tran, J.B.
 2013
 16 7 p. A604-A605
nvt p.
 artikel
2030 Using Multi-Criteria Decision Analysis to Support Allocation Decisions in Large Translational Research Projects De Graaf, G.
 2013
 16 7 p. A612-
1 p.
 artikel
2031 Using Rasch Analysis to Co-Calibrate Scores from Outcome Measures Specific to Asthma (ALIS), Chronic Obstructive Pulmonary Disease (LCOPD) and Pulmonary Hypertension (CAMPHOR) Twiss, J.
 2013
 16 7 p. A605-
1 p.
 artikel
2032 Using Saturn Plots to Describe Co-Morbidity Patterns Within Cohorts Juneau, P.
 2013
 16 7 p. A576-
1 p.
 artikel
2033 Using Structural Equation Modeling to Detect Response Shift and True Change in Health-Related Quality-Of-Life Scores of Breast Cancer Patients After Surgery Nakamura, K.
 2013
 16 7 p. A602-
1 p.
 artikel
2034 Using the Delphi Method for Selecting Medical Technologies Under Budget Constraints: A Feasibility Study Daichman, S.
 2013
 16 7 p. A482-
1 p.
 artikel
2035 Uso De Bases De Datos O Sistemas De Información Para Soportar La Toma De Decisiones En Salud En Colombia Alfonso-Cristancho, R.
 2013
 16 7 p. A700-
1 p.
 artikel
2036 Uterine-sparing Surgical Treatment Modalities in Women with Uterine Fibroids: A Systematic Review and Indirect Treatment Comparison Panagiotopoulou, N.
 2013
 16 7 p. A330-A331
nvt p.
 artikel
2037 Utilidad De Biomarcadores Cardiacos (Point of Care Testing) En El Area De Urgencias Y Su Impacto Económico Contreras, I.
 2013
 16 7 p. A665-A666
nvt p.
 artikel
2038 Utilisation and Costs of Inpatient and Outpatient Services Among Patients with Irritable Bowel Syndrome- A Study Using the Clinical Practice Research Datalink (CPRD) Murray-Thomas, T.
 2013
 16 7 p. A495-A496
nvt p.
 artikel
2039 Utilisation Pattern of GLP-1 Agonists in Combination with Basal Insulin in Patients with T2DM in the Norwegian Setting in One Year Levorsen, A.
 2013
 16 7 p. A443-
1 p.
 artikel
2040 UTILITIES FOR TYPE 2 DIABETES MELLITUS AND ASSOCIATED COMPLICATIONS Shingler, S.L.
 2013
 16 7 p. A445-
1 p.
 artikel
2041 Utility and Resource Use of an Australian Population of Psoriasis Patients Wilson, J.L.
 2013
 16 7 p. A508-
1 p.
 artikel
2042 Utility Mapping of the EORTC QLQ-C30 onto EQ-5D in Patients with Soft Tissue Sarcoma Amdahl, J.
 2013
 16 7 p. A419-
1 p.
 artikel
2043 Utility Values for Patients with Advanced Gastrointestinal Stromal Tumors (GIST) Treated with Regorafenib Versus Placebo in the Phase III Grid Trial Connolly, M.
 2013
 16 7 p. A419-
1 p.
 artikel
2044 Utility Values Used in National Institute for Health and Care Excellence (NICE) Technology Appraisals of Medicines for 4 Metastatic Cancers Burke, M.J.
 2013
 16 7 p. A420-
1 p.
 artikel
2045 Utilization of Anti Spasticity Drugs in Multiple Sclerosis: Analysis from an Italian Administrative Database Mantovani, L.G.
 2013
 16 7 p. A620-
1 p.
 artikel
2046 Utilization of Routine Data for Regionalized Epidemiology in Austria - The Example of Ischemic Heart Disease (ICD9 410-414) Endel, G.
 2013
 16 7 p. A540-
1 p.
 artikel
2047 Utilization of the Hungarian Publicly Financed Health Care System by Third (Non EU) Country Citizens Kovács, G.
 2013
 16 7 p. A487-
1 p.
 artikel
2048 Utilization Patterns for Treatment with Strong Opioids for Chronic Back Pain in Germany Theidel, U.
 2013
 16 7 p. A390-
1 p.
 artikel
2049 Utilizing Storytelling to Promote Rational Antibiotic Use in 9-11 Years Old School Children in Iran Soleymani, F.
 2013
 16 7 p. A456-
1 p.
 artikel
2050 Vaccine Timeliness: A Cost Analysis of the Implications of Delayed Vaccination Curran, D.
 2013
 16 7 p. A346-
1 p.
 artikel
2051 4-Valent Vaccine Patients – Statistical Assessment of a New Estimation Methodology Schroeder-Bernhardi, D.
 2013
 16 7 p. A585-
1 p.
 artikel
2052 Validación De Un Cuestionario Para Medir Riesgo De Cáncer De Piel Morales-Sánchez, M.A.
 2013
 16 7 p. A687-
1 p.
 artikel
2053 Validating an Indolent Non-Hodgkin’s Lymphoma (NHL) Cost-Effectiveness Analysis Model Using Two Software Tools: Key Implementation Considerations and Results Wehler, E.A.
 2013
 16 7 p. A589-
1 p.
 artikel
2054 Validating the Unidimensional Fatigue Impact Scale (U-FIS) for Use in Crohn’s Disease Wilburn, J.
 2013
 16 7 p. A499-
1 p.
 artikel
2055 Validation and Psychometric Evaluation of the German-Translated Hepatitis C Virus Patient Reported Outcomes (HCV-PRO) Health and Wellbeing Instrument in German HCV-Infected Patients Treated with Direct Acting Antivirals (DAAS) with or Without Ribavirin (RBV) Anderson, R.T.
 2013
 16 7 p. A363-
1 p.
 artikel
2056 Validation of Accept, a New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-life Arnould, B.
 2013
 16 7 p. A335-
1 p.
 artikel
2057 Validation of Disease States in Schizophrenia: Comparison of Cluster Analysis Between the United States and European Populations Thokagevistk, K.
 2013
 16 7 p. A610-
1 p.
 artikel
2058 Validation of Surrogate Endpoints in Advanced Solid Tumours: Systematic Review of Statistical Methods, Results, and Implications for Policy Makers Ciani, O.
 2013
 16 7 p. A327-
1 p.
 artikel
2059 Validation of the Crohn’s Life Impact Questionnaire (CLIQ), the First Patient-Reported Outcome Measure Specific to Adults with Crohn’s Disease Wilburn, J.
 2013
 16 7 p. A499-A500
nvt p.
 artikel
2060 Validation of the French Translated Version of the Osteoporosis Specific Morisky Medication Adherence Scale (OS-MMAS) in France Feudjo Tepie, M.
 2013
 16 7 p. A568-
1 p.
 artikel
2061 Validation of the Multiple Sclerosis International Quality of Life Questionnaire in Electronic Form Using Item Response Theory Gupta, S.
 2013
 16 7 p. A597-
1 p.
 artikel
2062 Validation of the WHOQOL-OLD in Taiwan Yao, G.
 2013
 16 7 p. A598-
1 p.
 artikel
2063 Validity of QOL Impact Attributions to Specific Diseases: A Multitrait-Multimethod Comparison Ware, J.E.
 2013
 16 7 p. A599-A600
nvt p.
 artikel
2064 Validity of Self-Reported Dose of Patients Using Wafarin in Clinical Practice Dumas, S.
 2013
 16 7 p. A532-
1 p.
 artikel
2065 Validity, Responsiveness and Reliability of the Arthritis-Specific Work Productivity Survey Assessing Work Productivity Within and Outside the Home in Patients with Psoriatic Arthritis Osterhaus, J.
 2013
 16 7 p. A601-
1 p.
 artikel
2066 Value Attributes of Generic Versus Branded Drugs in São Paulo, Brazil Ferraz, M.B.
 2013
 16 7 p. A338-
1 p.
 artikel
2067 Value-Based Pricing in the UK and Potential Patient Access Hurdles to Innovative Drugs Papadopoulou, K.
 2013
 16 7 p. A492-
1 p.
 artikel
2068 Value Chain Analysis for Cardiac Devices Lucas, F.
 2013
 16 7 p. A537-
1 p.
 artikel
2069 Value Judgments in Health Technology Assessment Process in Brazil Santoro Neto, L.
 2013
 16 7 p. A673-
1 p.
 artikel
2070 Value of Life: As Perceived by Physicians and the General Public Tichopad, A.
 2013
 16 7 p. A477-
1 p.
 artikel
2071 Variabilidade No Tratamento Do Cancer De Mama No Brasil Cherchiglia, M.L.
 2013
 16 7 p. A687-
1 p.
 artikel
2072 Variability in Hybrid Drug Availability and Pricing in Europe Flostrand, S.J.A.
 2013
 16 7 p. A329-
1 p.
 artikel
2073 Variability in Publically-Prescribed Drug Costs: The Role of Region, Age and Gender O Céilleachair, A.J.
 2013
 16 7 p. A464-A465
nvt p.
 artikel
2074 Variability of Clinical Practice for Bariatric Surgery in Spain Espallardo, O.
 2013
 16 7 p. A390-
1 p.
 artikel
2075 Variance Reduction Through Antithetic Variates as a Means of Developing Complex VBA Models with Reasonable Computation Times Bennett, H.
 2013
 16 7 p. A585-A586
nvt p.
 artikel
2076 Variances in Individuals’ Prescription Drug Costs in Ireland Walshe, V.
 2013
 16 7 p. A488-
1 p.
 artikel
2077 Variation in Treatment Patterns and Outcomes in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder Across European Countries Setyawan, J.
 2013
 16 7 p. A552-
1 p.
 artikel
2078 Variations in the Health Status of Irish Regions Kenneally, M.
 2013
 16 7 p. A485-
1 p.
 artikel
2079 Variations in Treatment Patterns and Disease Severity Among Patients with Psoriasis Receiving Their First Biologic in European Union Narayanan, S.
 2013
 16 7 p. A389-
1 p.
 artikel
2080 Varicella Vaccine as Post-Exposure Prophylaxis – a Cost-Effectiveness Analysis Chui, K.S.
 2013
 16 7 p. A357-
1 p.
 artikel
2081 Venous Thromboembolism in Gynae-Oncology Patients Post Surgery – Is Tinzaparin Prophylaxis an Effective Anticoagulant? Ibrahim, N.
 2013
 16 7 p. A513-A514
nvt p.
 artikel
2082 Waiting Times and Scheduling in Dermatological Practices in Germany Krensel, M.
 2013
 16 7 p. A510-
1 p.
 artikel
2083 Web-Based of Topic Selection for Comparative Effectiveness Research in Korea Kim, H.S.
 2013
 16 7 p. A484-
1 p.
 artikel
2084 Weight- and Health-Related Quality of Life (WRQoL and HRQoL) with Canagliflozin (CANA) Versus Sitagliptin (SITA) in Subjects with Type 2 Diabetes Mellitus (T2DM) on Background Metformin Traina, S.B.
 2013
 16 7 p. A448-
1 p.
 artikel
2085 Weight Loss of ≥3% in Type II Diabetes Patients Is Associated with Weight Change Property of Newly Prescribed Anti-Diabetic Medicine in Anti-Depressant Users Over a 12-Month Follow-Up Period Lin, C.C.
 2013
 16 7 p. A431-
1 p.
 artikel
2086 Wellbeing, Life Satisfaction and Progression in Alzheimer’s Disease – An Alsova Follow-Up Study Väätäinen, S.
 2013
 16 7 p. A627-
1 p.
 artikel
2087 What Are the Clinical and Economic Costs and Benefits of Implementing Point of Care Tests for Chlamydia Trachomatis and Neisseria Gonorrhoea in Genito-Urinary Medicine Clinics in the United Kingdom? Turner, K.M.
 2013
 16 7 p. A351-
1 p.
 artikel
2088 What are the Key Drivers of Reimbursement for Biosimilars? An Examination of Reimbursement Processes and Recommendations Across Nine Countries de Silva, S.U.
 2013
 16 7 p. A323-
1 p.
 artikel
2089 What Clinical Benefits Could Be Expected from the Implementation of a Rotavirus Vaccination Programme in France? Yamin, D.
 2013
 16 7 p. A360-
1 p.
 artikel
2090 What Factors Predict the Decision to Treat Acute Coronary Syndrome Invasively? Evidence from Clinical Practice Fakhouri, W.K.
 2013
 16 7 p. A539-
1 p.
 artikel
2091 What Value Can Operational Feasibility Studies Bring to Post Marketing Observational Studies (PMOS)? Example of Feasibility Study Performed in Eastern Europe to Assess Hepatitis C Viral Disease/Patient Management in Real World Setting El Kebir, S.
 2013
 16 7 p. A613-
1 p.
 artikel
2092 When Treatment Is Mitigated by Adverse Events: The Economic Impact of Treatment-Associated Adverse Events in Cirrhotic Non-Responders Treated with Boceprevir or Telaprevir and Peginterferon Alpha/Ribavirin Sullivan, S.
 2013
 16 7 p. A350-A351
nvt p.
 artikel
2093 Which Are the Attitudes of Primary Health Services Users Concerning Cost Sharing Measures in a Period of Economic Crisis in Greece? Siskou, O.
 2013
 16 7 p. A463-
1 p.
 artikel
2094 Which Cystic Fibrosis Inhaled Antibiotic Medicine Features Matter Most to Adult Patients and Parents of Pediatric Patients? Mohamed, A.F.
 2013
 16 7 p. A722-
1 p.
 artikel
2095 Which Should Be the Correct NMA to Be Used? A Review of HTA Recommendations Solozabal, M.
 2013
 16 7 p. A482-A483
nvt p.
 artikel
2096 Who Knows Better? A Knowledge, Attitude and Practice Survey of Osteoporosis Prescreening Tools Among Pharmacists and Physicians Khan, Y.
 2013
 16 7 p. A451-
1 p.
 artikel
2097 Willingness to Pay (WTP) for a Brand Name Drug in Sâo Paulo, Brazil Ferraz, M.B.
 2013
 16 7 p. A338-A339
nvt p.
 artikel
2098 WITHDRAWN 2013
 16 7 p. A628-
1 p.
 artikel
2099 Workforce Participation and Productivity Losses After Head and Neck Cancer Pearce, A.M.
 2013
 16 7 p. A418-
1 p.
 artikel
2100 Work Impairment Burden of Anxiety and Depression in Germany Pisa, G.
 2013
 16 7 p. A551-
1 p.
 artikel
2101 Work Productivity Loss Due to Rheumatoid Arthritis in Poland. Results of Cross-Sectional Study of Outpatients with Chronic Inflammatory Diseases and Comparison with Selected Studies Wladysiuk, M.
 2013
 16 7 p. A560-A561
nvt p.
 artikel
2102 Workshop in Pharmacoeconomics: An Italian Experience of Multi-Stakeholder Hta Consensus Cicchetti, A.
 2013
 16 7 p. A479-A480
nvt p.
 artikel
2103 Would a New Therapy for Children Be Refused in the Context of the German Amnog? Walzer, S.
 2013
 16 7 p. A339-
1 p.
 artikel
2104 2.5 YEARS OF AMNOG IN GERMANY – AN ANALYSIS OF BENEFIT ASSESSMENT AND NET PRICE NEGOTIATION TRENDS Dehnen, J.
 2013
 16 7 p. A456-A457
nvt p.
 artikel
                             2104 gevonden resultaten
 
<< vorige   
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland